Analytical framework to evaluate and optimize the use of imperfect diagnostics to inform outbreak response : Application to the 2017 plague epidemic in Madagascar
During outbreaks, the lack of diagnostic "gold standard" can mask the true burden of infection in the population and hamper the allocation of resources required for control. Here, we present an analytical framework to evaluate and optimize the use of diagnostics when multiple yet imperfect diagnostic tests are available. We apply it to laboratory results of 2,136 samples, analyzed with 3 diagnostic tests (based on up to 7 diagnostic outcomes), collected during the 2017 pneumonic (PP) and bubonic plague (BP) outbreak in Madagascar, which was unprecedented both in the number of notified cases, clinical presentation, and spatial distribution. The extent of these outbreaks has however remained unclear due to nonoptimal assays. Using latent class methods, we estimate that 7% to 15% of notified cases were Yersinia pestis-infected. Overreporting was highest during the peak of the outbreak and lowest in the rural settings endemic to Y. pestis. Molecular biology methods offered the best compromise between sensitivity and specificity. The specificity of the rapid diagnostic test was relatively low (PP: 82%, BP: 85%), particularly for use in contexts with large quantities of misclassified cases. Comparison with data from a subsequent seasonal Y. pestis outbreak in 2018 reveal better test performance (BP: specificity 99%, sensitivity: 91%), indicating that factors related to the response to a large, explosive outbreak may well have affected test performance. We used our framework to optimize the case classification and derive consolidated epidemic trends. Our approach may help reduce uncertainties in other outbreaks where diagnostics are imperfect.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
PLoS biology - 20(2022), 8 vom: 17. Aug., Seite e3001736 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ten Bosch, Quirine [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 29.08.2022 Date Revised 09.10.2022 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.1371/journal.pbio.3001736 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM344883183 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM344883183 | ||
| 003 | DE-627 | ||
| 005 | 20231226023806.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1371/journal.pbio.3001736 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1149.xml |
| 035 | |a (DE-627)NLM344883183 | ||
| 035 | |a (NLM)35969599 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ten Bosch, Quirine |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Analytical framework to evaluate and optimize the use of imperfect diagnostics to inform outbreak response |b Application to the 2017 plague epidemic in Madagascar |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.08.2022 | ||
| 500 | |a Date Revised 09.10.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a During outbreaks, the lack of diagnostic "gold standard" can mask the true burden of infection in the population and hamper the allocation of resources required for control. Here, we present an analytical framework to evaluate and optimize the use of diagnostics when multiple yet imperfect diagnostic tests are available. We apply it to laboratory results of 2,136 samples, analyzed with 3 diagnostic tests (based on up to 7 diagnostic outcomes), collected during the 2017 pneumonic (PP) and bubonic plague (BP) outbreak in Madagascar, which was unprecedented both in the number of notified cases, clinical presentation, and spatial distribution. The extent of these outbreaks has however remained unclear due to nonoptimal assays. Using latent class methods, we estimate that 7% to 15% of notified cases were Yersinia pestis-infected. Overreporting was highest during the peak of the outbreak and lowest in the rural settings endemic to Y. pestis. Molecular biology methods offered the best compromise between sensitivity and specificity. The specificity of the rapid diagnostic test was relatively low (PP: 82%, BP: 85%), particularly for use in contexts with large quantities of misclassified cases. Comparison with data from a subsequent seasonal Y. pestis outbreak in 2018 reveal better test performance (BP: specificity 99%, sensitivity: 91%), indicating that factors related to the response to a large, explosive outbreak may well have affected test performance. We used our framework to optimize the case classification and derive consolidated epidemic trends. Our approach may help reduce uncertainties in other outbreaks where diagnostics are imperfect | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Andrianaivoarimanana, Voahangy |e verfasserin |4 aut | |
| 700 | 1 | |a Ramasindrazana, Beza |e verfasserin |4 aut | |
| 700 | 1 | |a Mikaty, Guillain |e verfasserin |4 aut | |
| 700 | 1 | |a Rakotonanahary, Rado J L |e verfasserin |4 aut | |
| 700 | 1 | |a Nikolay, Birgit |e verfasserin |4 aut | |
| 700 | 1 | |a Rahajandraibe, Soloandry |e verfasserin |4 aut | |
| 700 | 1 | |a Feher, Maxence |e verfasserin |4 aut | |
| 700 | 1 | |a Grassin, Quentin |e verfasserin |4 aut | |
| 700 | 1 | |a Paireau, Juliette |e verfasserin |4 aut | |
| 700 | 1 | |a Rahelinirina, Soanandrasana |e verfasserin |4 aut | |
| 700 | 1 | |a Randremanana, Rindra |e verfasserin |4 aut | |
| 700 | 1 | |a Rakotoarimanana, Feno |e verfasserin |4 aut | |
| 700 | 1 | |a Melocco, Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Rasolofo, Voahangy |e verfasserin |4 aut | |
| 700 | 1 | |a Pizarro-Cerdá, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Le Guern, Anne-Sophie |e verfasserin |4 aut | |
| 700 | 1 | |a Bertherat, Eric |e verfasserin |4 aut | |
| 700 | 1 | |a Ratsitorahina, Maherisoa |e verfasserin |4 aut | |
| 700 | 1 | |a Spiegel, André |e verfasserin |4 aut | |
| 700 | 1 | |a Baril, Laurence |e verfasserin |4 aut | |
| 700 | 1 | |a Rajerison, Minoarisoa |e verfasserin |4 aut | |
| 700 | 1 | |a Cauchemez, Simon |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t PLoS biology |d 2003 |g 20(2022), 8 vom: 17. Aug., Seite e3001736 |w (DE-627)NLM12680690X |x 1545-7885 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2022 |g number:8 |g day:17 |g month:08 |g pages:e3001736 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1371/journal.pbio.3001736 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2022 |e 8 |b 17 |c 08 |h e3001736 | ||